NORTHROP GRUMMAN CORP /DE/ Quarterly Liabilities and Equity in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Northrop Grumman Corp /De/ quarterly Liabilities and Equity history and growth rate from Q1 2010 to Q3 2024.
  • Northrop Grumman Corp /De/ Liabilities and Equity for the quarter ending September 30, 2024 was $48.3B, a 7.56% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $48.3B +$3.39B +7.56% Sep 30, 2024 10-Q 2024-10-24
Q2 2024 $47.7B +$2.06B +4.52% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $47.8B +$3.57B +8.08% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $46.5B +$2.79B +6.37% Dec 31, 2023 10-Q 2024-10-24
Q3 2023 $44.9B +$2.16B +5.06% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $45.6B +$3.7B +8.82% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $44.2B +$2.34B +5.59% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $43.8B +$1.18B +2.76% Dec 31, 2022 10-K 2024-01-25
Q3 2022 $42.7B +$387M +0.91% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $41.9B -$228M -0.54% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $41.9B +$480M +1.16% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $42.6B -$1.89B -4.25% Dec 31, 2021 10-K 2023-01-26
Q3 2021 $42.3B -$2.43B -5.42% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $42.1B -$1.33B -3.07% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $41.4B -$1.78B -4.12% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $44.5B +$3.38B +8.23% Dec 31, 2020 10-K 2022-01-27
Q3 2020 $44.8B +$4.22B +10.4% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 $43.5B +$3.89B +9.83% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $43.2B +$3.45B +8.68% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $41.1B +$3.44B +9.13% Dec 31, 2019 10-K 2021-01-28
Q3 2019 $40.6B +$2.61B +6.88% Sep 30, 2019 10-Q 2019-10-24
Q2 2019 $39.6B +$2.21B +5.9% Jun 30, 2019 10-Q 2019-07-24
Q1 2019 $39.8B +$4.96B +14.2% Mar 31, 2019 10-Q 2019-04-24
Q4 2018 $37.7B +$2.53B +7.19% Dec 31, 2018 8-K 2020-04-29
Q3 2018 $37.9B +$11.4B +43.1% Sep 30, 2018 10-Q 2018-10-24
Q2 2018 $37.4B +$11.6B +44.8% Jun 30, 2018 10-Q 2018-07-25
Q1 2018 $34.8B +$9.38B +36.9% Mar 31, 2018 10-Q 2018-04-25
Q4 2017 $35.1B +$9.51B +37.1% Dec 31, 2017 10-K 2019-01-31
Q3 2017 $26.5B +$2.41B +10% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 $25.8B +$1.73B +7.19% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $25.4B +$1.48B +6.18% Mar 31, 2017 10-Q 2017-04-26
Q4 2016 $25.6B +$1.19B +4.87% Dec 31, 2016 10-K 2018-01-29
Q3 2016 $24.1B +$134M +0.56% Sep 30, 2016 10-Q 2016-10-26
Q2 2016 $24.1B -$471M -1.92% Jun 30, 2016 10-Q 2016-07-27
Q1 2016 $23.9B -$1.33B -5.28% Mar 31, 2016 10-Q 2016-04-27
Q4 2015 $24.4B -$2.15B -8.08% Dec 31, 2015 10-K 2017-01-30
Q3 2015 $24B -$1.08B -4.3% Sep 30, 2015 10-Q 2015-10-28
Q2 2015 $24.6B -$799M -3.15% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 $25.3B -$269M -1.05% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $26.6B +$191M +0.72% Dec 31, 2014 8-K 2016-04-27
Q3 2014 $25B -$2.36B -8.62% Sep 30, 2014 10-Q 2014-10-22
Q2 2014 $25.4B -$2.16B -7.84% Jun 30, 2014 10-Q 2014-07-23
Q1 2014 $25.5B -$379M -1.46% Mar 31, 2014 10-Q 2014-04-23
Q4 2013 $26.4B -$162M -0.61% Dec 31, 2013 10-K 2015-02-02
Q3 2013 $27.4B +$2.14B +8.48% Sep 30, 2013 10-Q 2013-10-23
Q2 2013 $27.5B +$2.28B +9.05% Jun 30, 2013 10-Q 2013-07-24
Q1 2013 $25.9B +$861M +3.44% Mar 31, 2013 10-Q 2013-04-24
Q4 2012 $26.5B +$1.13B +4.46% Dec 31, 2012 10-K 2014-02-03
Q3 2012 $25.3B +$162M +0.65% Sep 30, 2012 10-Q 2012-10-24
Q2 2012 $25.2B -$151M -0.6% Jun 30, 2012 10-Q 2012-07-25
Q1 2012 $25.1B -$1.74B -6.48% Mar 31, 2012 10-Q 2012-04-25
Q4 2011 $25.4B -$6B -19.1% Dec 31, 2011 10-K 2013-02-05
Q3 2011 $25.1B -$5.08B -16.8% Sep 30, 2011 10-Q 2011-10-26
Q2 2011 $25.4B -$4.32B -14.5% Jun 30, 2011 10-Q 2011-07-27
Q1 2011 $26.8B -$2.97B -9.99% Mar 31, 2011 10-Q 2011-04-27
Q4 2010 $31.4B Dec 31, 2010 10-K 2012-02-08
Q3 2010 $30.2B Sep 30, 2010 10-Q 2010-10-27
Q2 2010 $29.7B Jun 30, 2010 10-Q 2010-07-29
Q1 2010 $29.8B Mar 31, 2010 10-Q 2010-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.